個股熱度排行 | 12月30日美股盤前
根據uSMART輿情監測數據,從29日晚間到30日美股盤前時間段,中國投資者關注指數最高的4只股票是高盛、京東、生化基因、花旗銀行。
12月30日—美股關注排行TOP4

高盛

關注度第一爲高盛,該股上個交易日收盤下跌0.36%,報於386.20美元。近5個交易日累計上漲1.55%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
高盛增持凱萊英12.1萬股,每股作價約316.84港元
高盛回顧2021年金融熱點:通脹、破紀錄的低利率......
京東

關注度第二爲京東,該股上個交易日收盤下跌0.36%,報於65.63美元。近5個交易日累計下跌10.60%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:
淘寶、京東等平臺及相關主播向消保部門提交整改報告
Taobao, JD etc., Relevant Streamers Submit Rectification Reports to Consumer Council
生化基因

關注度第三爲生化基因,該股上個交易日收盤上漲9.46%,報於258.31美元。近5個交易日累計上漲10.08%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:
傳三星正與百健洽談收購事宜,Jefferies表示恐存在估值困難
渤健盤前跌5% 三星否認溢價收購傳聞
花旗銀行

關注度第四爲花旗銀行,該股上個交易日收盤下跌0.13%,報於60.54美元。近5個交易日累計上漲1.95%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
花旗削華潤醫療目標價32.5%至5.2港元 維持“中性”評級
花旗:未來受益於電動汽車,通用汽車股價有望達200美元
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.